Sole Source For Influenza Quadrivalent Vaccine

Name: Sole Source For Influenza Quadrivalent Vaccine
Start: 2025-06-08
End: 2025-06-13
Location: HOMELAND SECURITY, DEPARTMENT OF

HOMELAND SECURITY, DEPARTMENT OF United States has Released a tender for Sole Source For Influenza Quadrivalent Vaccine in Healthcare Equipment and Services. The tender was released on Jun 07, 2025.

Country - United States

Summary - Sole Source For Influenza Quadrivalent Vaccine

Deadline - login to view

GT reference number - 110550930

Product classification - Post-mortem and mortuary equipment and supplies

Organization Details:

Address - United States

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 110550930

Document Type - Tender Notices

Login

Notice Details and Documents:

Description - Description: Please see the attachments. This requirment is for the purchase of the Fluzone vaccine.local title:: Sole source for Influenza QUADRIVALENT vaccinelocal description: : Please see the attachments. This requirment is for the purchase of th e Fluzone vaccine.

Gt Ref Id - 110550930

Deadline - Jun 13, 2025

Login

Share

Similar Tenders :

Summary:

Supply of Medicine and Medical / Surgical equipments : Lidocaine 2.5% & Prilocaine 2.5% cream 5g Tube\nLidocaine 2.5% w/w and Prilocaine 2.5%w/w Cream\n5g Tube\nEach 5g collapsible tube to contain Lidocaine\nBP/USP 2.5%w/w and Prilocaine BP/USP 2.5% w/w\nin a suitable cream base for topical anaesthesia.\nNote:\n1. This product should be stable for a minimum of 24\nmonths at a temperature range of 28'C-32'C\n2. Each collapsible tube should be labelled\naccoprdingly.\n3. This product should be supplied together with\nocclusive dressing.\nPack: 5g in air tight sealed printed collapsible tubes,\nin printed cartons.\nPacking : One Tubes in a Pack etc .

Summary:

Supply of Medicine and Medical / Surgical equipments : Cyclophosphamide Tablet 50mg\nCyclophosphamide Tablet BP/USP 50mg\nEach coated tablet to contain Cyclophosphamide BP etc .

Summary:

Supply of Medicine and Medical / Surgical equipments : Rabies Vaccine (Human use) 0.5mL/1mL-\nInactivated\nRabies Vaccine (Human use)(0.5ml/1ml).\nEach dose 0.1ml to contain at least 7 IU/ml of rabies\nAntigen as an inactivated freeze-dried powder form.\nEach vial should be either 0.5mL or 1mL.\nThe Vaccine should be suitable for human use,\nproduced in cell culture.(Eg. Primary chickembryo cell\nculture Rabies Vaccine, Vero cell Rabies Vaccine).\nThe vaccine should comply with the Rabies Vaccine\nas the Pharmacopoeial requirement of Vaccine and\nbiological products.\nNote:\n1.Cold Chain monitors or WHO recommended other\ncold chain monitoring device should be included for\neach cartoon and the cold chain should be\nmaintained according to the manufacturer’s\ninstructions during storage, transport & delivery of\nvaccine.\n2.The following documents should be submitted pre-\nshipment for each lot of vaccine dispatched.\n(a).Invoice (b).Certificate of origin (c).Certificate of\nanalysis. (d).Lot release certificate from National\nControl Laboratory (NCL) from country of\norigin.(e).Summary lot protocols of production\nprocedure & quality control testing. (f) Packing list.\n(g) Copy of product information leaflet (PIL).These\ndocuments should be submitted pre-shipment to the\nNational Control Laboratory for Vaccines (NCL-MRI)\nSri Lanka. etc .

Summary:

Supply of Medicine and Medical / Surgical equipments : 7,000 Vials of Infliximab etc .

Summary:

Microtomo

Sole Source For Influenza Quadrivalent Vaccine

HOMELAND SECURITY, DEPARTMENT OF United States has Released a tender for Sole Source For Influenza Quadrivalent Vaccine in Healthcare Equipment and Services. The tender was released on Jun 07, 2025.

Organization Details:

Notice Details and Documents:

Create Account